Cinanserin
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Cinanserin (INN) is a 5-HT2A and 5-HT2C receptor antagonist which was discovered in the 1960s.[1][2] It showed about 50-fold higher affinity for the serotonin 5-HT2A receptor over the serotonin 5-HT2C receptor and had very low affinity for the serotonin 5-HT1 receptors.[2]
The molecule is an inhibitor of the 3C-like protease of SARS-CoV-1[3] and SARS-CoV-2.[4]
See also
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".